Cargando…

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report

Pulmonary pleomorphic carcinoma (PPC) has a poor prognosis due to the poor results of treatment with systemic chemotherapy. We report the case of a 73-year-old woman with PPC who showed a favorable response to nivolumab. As first-line treatment for postoperative recurrence, she received carboplatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Eriko, Yokoi, Takashi, Mikami, Koji, Kanemura, Shingo, Shibata, Eisuke, Horio, Daisuke, Koda, Yuichi, Negi, Yoshiki, Akano, Yumiko, Tada, Akio, Minami, Toshiyuki, Kuribayashi, Kozo, Kijima, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006649/ https://www.ncbi.nlm.nih.gov/pubmed/29928213 http://dx.doi.org/10.1159/000489392

Ejemplares similares

Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma
por: Horio, Daisuke, et al.
Publicado: (2020)

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
por: Yoshikawa, Yoshie, et al.
Publicado: (2020)

Usefulness of Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluating the Treatment Response of Bone Metastasis in a Lung Cancer Patient
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
por: Watanabe, Shohei, et al.
Publicado: (2021)

Pemetrexed for epithelioid haemangioendothelioma of the pleura
por: Kanemura, Shingo, et al.
Publicado: (2016)

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab
por: Senoo, Satoru, et al.
Publicado: (2018)

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013)

Case series of pleomorphic carcinomas of the lung treated with nivolumab
por: Kanazu, Masaki, et al.
Publicado: (2017)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report
por: Yoshimura, Akihiro, et al.
Publicado: (2018)

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
por: Minami, Seigo, et al.
Publicado: (2015)

Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma
por: Furuya, Naoki, et al.
Publicado: (2020)

Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post‐surgical recurrence
por: Yaguchi, Daizo, et al.
Publicado: (2019)

Nivolumab in the treatment of malignant melanoma: review of the literature
por: Mashima, Emi, et al.
Publicado: (2015)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab
por: Okamura, Kazuaki, et al.
Publicado: (2017)

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
por: Osa, Akio, et al.
Publicado: (2018)

Immunohistochemical Characteristics of Bone Forming Cells in Pleomorphic Adenoma
por: Nakano, Keisuke, et al.
Publicado: (2007)

Undifferentiated pleomorphic sarcoma of the prostate in a young man
por: Iwahashi, Yuya, et al.
Publicado: (2020)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102
por: Yokoi, Takashi, et al.
Publicado: (2019)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma
por: Katsuya, Yuki, et al.
Publicado: (2023)

Molecular profile of a pleomorphic adenoma of the hard palate: A case report
por: Iida, Yoshiyuki, et al.
Publicado: (2020)

Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report
por: Yasuoka, Shotaro, et al.
Publicado: (2018)

A Case of Pleomorphic Xanthoastrocytoma with Intracranial Hemorrhage in a Child
por: Takamine, Yusuke, et al.
Publicado: (2018)

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors
por: Yamamoto, Noboru, et al.
Publicado: (2016)

Pleomorphic adenoma: a rare presentation in buccal salivary gland with extensive squamous and mucous metaplasia
por: Urs, Aadithya Basavaraj, et al.
Publicado: (2019)

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
por: Niwa, Kazutomo, et al.
Publicado: (2020)

A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab
por: Kokubun, Hidetoshi, et al.
Publicado: (2023)

Carcinoma ex pleomorphic adenoma of the sublingual gland: a case report
por: Ariyoshi, Yasunori, et al.
Publicado: (2012)

Perioperative Bypassing Agent Therapy for Pulmonary Pleomorphic Carcinoma with Acquired Hemophilia
por: Sakai, Takashi, et al.
Publicado: (2021)

A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report
por: Iso, Hirokazu, et al.
Publicado: (2023)

Bovine leukemia virus-associated B cell lymphoma with severe pleomorphism in a steer
por: HAGIWARA, Akiyo, et al.
Publicado: (2022)

A case of cerebral infarction due to pleomorphic carcinoma of the lung
por: Yoshikawa, Shinichiro, et al.
Publicado: (2020)

Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
por: Sakoh, Takashi, et al.
Publicado: (2019)

Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study
por: Yamazaki, Naoya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c81np8vtv52s2eogulr6duf55r